FindTrial
Sign In

A study of the effectiveness of a graded management program for acute moderate to severe pain prevention after HAIC in hepatocellular carcinoma patients

Construction and clinical empirical study of a graded management scheme for acute moderate-to-severe pain prevention after HAIC in hepatocellular carcinoma patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400091879
Enrollment
Unknown
Registered
2024-11-05
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

control:Routine management, patients are admitted to the hospital for pain education, informing patients of the methods of pain assessment, informing patients of the emergence of pain and timely repor
intervention:Risk assessment of acute postoperative moderate and severe pain is carried out before surgery, and individualised preventive programmes are implemented according to risk stratification, e

Sponsors

Fudan University Shanghai Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients =18 years of age, diagnosed with hepatocellular carcinoma by histopathological examination or imaging, undergoing HAIC, conscious and with informed patient consent

Exclusion criteria

Exclusion criteria: Cognitive impairment; use of psychotropic medications; inability to cooperate with pain scoring

Design outcomes

Primary

MeasureTime frame
Incidence and severity of acute moderate to severe pain after HAIC;—

Secondary

MeasureTime frame
Dosage of pain medication in the first 24 hours after HAIC;Number of occurrences of acute moderate to severe pain within 24 hours after HAIC ;Cost of pain management;Incidence of adverse effects of analgesics;—

Countries

China

Contacts

Public ContactZhao Wenjuan

Fudan university shanghai cancer center

more1011@aliyun.com+86 158 0085 7465

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026